Funder
Bill and Melinda Gates Foundation
Publisher
Springer Science and Business Media LLC
Reference41 articles.
1. De Oliveira DMP, Forde BM, Kidd TJ, Harris PNA, Schembri MA, Beatson SA, Paterson DL, Walker MJ. Antimicrobial Resistance in ESKAPE Pathogens. Clin Microbiol Rev. 2020;33. https://doi.org/10.1128/CMR.00181-19
2. Centers for Disease Control and Prevention (U.S.). Antibiotic resistance threats in the United States, 2019. Centers for Disease Control and Prevention (U.S.); 2019.
3. Bhagirath AY, Li Y, Somayajula D, Dadashi M, Badr S, Duan K. Cystic fibrosis lung environment and Pseudomonas aeruginosa infection. BMC Pulm Med. 2016;16:174.
4. Sivanmaliappan TS, Sevanan M. Antimicrobial susceptibility patterns of pseudomonas aeruginosa from diabetes patients with foot ulcers. Int J Microbiol. 2011;2011:605195.
5. Pachori P, Gothalwal R, Gandhi P. Emergence of antibiotic resistance Pseudomonas aeruginosa in intensive care unit; a critical review. Genes Dis. 2019;6:109–19.